Business Description
Willow Biosciences Inc
NAICS : 325412
SIC : 3741
ISIN : CA56087W2067
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.49 | |||||
Equity-to-Asset | 0.06 | |||||
Debt-to-Equity | 9.02 | |||||
Debt-to-EBITDA | -0.31 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -60.38 | |||||
Beneish M-Score | -7.72 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 38.1 | |||||
3-Year EPS without NRI Growth Rate | 19.8 | |||||
3-Year FCF Growth Rate | 17.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 60.57 | |||||
9-Day RSI | 50.96 | |||||
14-Day RSI | 48.23 | |||||
6-1 Month Momentum % | 18.75 | |||||
12-1 Month Momentum % | 26.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.8 | |||||
Quick Ratio | 0.76 | |||||
Cash Ratio | 0.44 | |||||
Days Sales Outstanding | 31.37 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.8 | |||||
Shareholder Yield % | -8.83 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -267.17 | |||||
Net Margin % | -268.91 | |||||
FCF Margin % | -157.34 | |||||
ROE % | -354.48 | |||||
ROA % | -145.39 | |||||
ROIC % | -234.59 | |||||
ROC (Joel Greenblatt) % | -305.2 | |||||
ROCE % | -209.64 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.05 | |||||
PB Ratio | 85 | |||||
EV-to-EBIT | -1.86 | |||||
EV-to-EBITDA | -2.32 | |||||
EV-to-Revenue | 4.58 | |||||
EV-to-FCF | -2.75 | |||||
Earnings Yield (Greenblatt) % | -53.71 | |||||
FCF Yield % | -36.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Willow Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 2.869 | ||
EPS (TTM) (C$) | -0.05 | ||
Beta | 1.32 | ||
Volatility % | 70.89 | ||
14-Day RSI | 48.23 | ||
14-Day ATR (C$) | 0.004873 | ||
20-Day SMA (C$) | 0.08625 | ||
12-1 Month Momentum % | 26.67 | ||
52-Week Range (C$) | 0.07 - 0.15 | ||
Shares Outstanding (Mil) | 144.2 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Willow Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Willow Biosciences Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Willow Biosciences Inc Frequently Asked Questions
What is Willow Biosciences Inc(TSX:WLLW)'s stock price today?
When is next earnings date of Willow Biosciences Inc(TSX:WLLW)?
Does Willow Biosciences Inc(TSX:WLLW) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |